ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 117 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $971,042 | -51.6% | 141,758 | -26.8% | 0.18% | -48.9% |
| Q2 2023 | $2,007,601 | +49.5% | 193,597 | +16.6% | 0.35% | +19.2% |
| Q1 2023 | $1,343,102 | -65.5% | 166,020 | -32.8% | 0.29% | -71.8% |
| Q4 2022 | $3,892,754 | +5.9% | 247,159 | +5.8% | 1.04% | -0.8% |
| Q3 2022 | $3,677,000 | -13.6% | 233,626 | -23.4% | 1.04% | -33.3% |
| Q2 2022 | $4,256,000 | -63.0% | 304,843 | -54.4% | 1.57% | -53.5% |
| Q1 2022 | $11,518,000 | -22.8% | 668,098 | -34.9% | 3.37% | +2.5% |
| Q4 2021 | $14,911,000 | -36.6% | 1,025,522 | -21.5% | 3.29% | -44.7% |
| Q3 2021 | $23,516,000 | -10.8% | 1,306,460 | -13.0% | 5.95% | +3.2% |
| Q2 2021 | $26,366,000 | -38.8% | 1,501,460 | -12.2% | 5.76% | -42.3% |
| Q1 2021 | $43,070,000 | +255.0% | 1,709,136 | -8.9% | 10.00% | +221.5% |
| Q4 2020 | $12,133,000 | +156.2% | 1,875,336 | +1.8% | 3.11% | +147.9% |
| Q3 2020 | $4,736,000 | +72.2% | 1,842,661 | +8.6% | 1.25% | +61.8% |
| Q2 2020 | $2,750,000 | +72.0% | 1,697,357 | +10.4% | 0.78% | +4.6% |
| Q1 2020 | $1,599,000 | +276.2% | 1,537,357 | +583.3% | 0.74% | +502.4% |
| Q4 2019 | $425,000 | – | 225,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |